Trial intelligence / Profile preview

Hypertonic Saline for Acute Viral Bronchiolitis

NCT02045238Terminated

Sponsor
Universidade de São Paulo
Start
Jul 2013
Primary completion
Dec 2014
Modality
Small Molecules, Device-based Delivery
Countries
1
01

Overview

Randomised trial of hypertonic saline in bronchiolitis (2 arms), sponsored by Universidade de São Paulo. Primary endpoints: Rate of Admission at 24 hours and Time to Attain Discharge Criteria at 24 hours. Started Jul 2013; status: terminated.

02

Drugs

hypertonic saline
03

Conditions

bronchiolitis

Beyond the preview

Go deeper on NCT02045238.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02045238.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call